BGI LifeTech to Sell DNAStar's Software in China, Hong Kong | GenomeWeb

NEW YORK (GenomeWeb News) — The Beijing Genomics Institute’s BGI LifeTech segment will sell DNAStar’s bioinformatics software in China and Hong Kong, DNAStar said today.

Under the agreement, BGI LifeTech has acquired the rights to sell the Lasergene, ArrayStar, Seqman Genome Assembler, and GenVision products.
 
The company’s software platforms are used in analyzing sequence data, microarray gene expression data, and genomic visualizations.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.